Head-to-Head: which pill tames high blood pressure better in younger adults?

NCT ID NCT07327749

Completed Disease control Sponsor: Shiraz University of Medical Sciences Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study tested two different blood pressure treatments in 59 adults under 60 who were newly diagnosed with hypertension. One group took bisoprolol alone, while the other took a combination pill containing valsartan and amlodipine. The goal was to see which approach better controlled blood pressure over 24 hours, including nighttime readings. Researchers also tracked any side effects reported by participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bisoprolol and a valsartan-amlodipine combination pill
What this could lead to: If one drug works better, it could offer a simpler or more effective first-choice treatment for high blood pressure in younger adults.
What could go wrong: This is a small, completed Phase 4 trial with only 59 participants, so results may not apply to everyone. Both drugs have known side effects like dizziness or fatigue.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hypertensive disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION

Contacts and locations

Locations

professor Kojuri cardiology clinic

Shiraz, Fars, 55318, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.